Peer-Reviewed Journal Details
Mandatory Fields
Ali, RAR,Egan, LJ
2007
June
Best Practice & Research In Clinical Gastroenterology
Gastroesophageal reflux disease in pregnancy
Published
()
Optional Fields
gastroesophageal reflux disease heartburn pregnancy histamine-2 receptor antagonists proton pump inhibitors PROTON PUMP INHIBITORS DRUG-USE HEARTBURN RANITIDINE SPHINCTER METOCLOPRAMIDE NIZATIDINE OMEPRAZOLE MANAGEMENT CIMETIDINE
21
793
806
Gastroesophageal reflux disease during pregnancy is common. Altered structure and function of the normal physiological barriers to reflux of gastric contents into the oesophagus explain the high incidence of this problem in pregnant women. For the majority of patients, life-style modifications are helpful, but are not sufficient to control symptoms and medication is required. The optimum management of reflux in pregnant patients requires special attention and expertise, since the safety of the mother, foetus and neonate remain the primary focus. Gastroenterologists and obstetricians should work together to optimise treatment. Typically, one utilises a step-up program that starts with life-style modifications and antacids. If those methods fail, hista-mine-2 receptor antagonists and proton pump inhibitors are tried. Rarely, promotility agents are used. Initiation of these medications must be undertaken after a careful discussion of risks and benefits with patients. In patients without a prior history of reflux, symptoms usually abate after delivery.
DOI 10.1016/j.bpg.2007.05.006
Grant Details
Publication Themes